MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring

F. Chmell, P. Lee, M. Sander (München, Germany)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease (Other)

Objective: This project evaluates how AI-driven continuous monitoring and wearable sensors can support Parkinson’s disease (PD) nurses in optimizing medication schedules, assessing treatment efficacy, and detecting early signs of disease progression.

Background: PD nurses play a vital role in patient care, providing education, symptom management, and emotional support. Traditional assessments rely on infrequent clinical visits, subjective patient reports, and caregiver observations, prone to biases and are inadequate to enable precision care. AI-driven wearable sensors offer continuous monitoring, enabling data-driven decisions, proactive interventions, and personalized care.

Method: In this real-world pilot project, individuals with PD wore smartwatches that continuously tracked motion data. Data was processed by an AI algorithm in the cloud to generate symptom and treatment response insights. PD nurses accessed this data before and during online consultations to enhance patient discussions and optimize care. Three cases illustrate the potential of a novel AI-assisted nurse care model.

Results: A 73-year-old woman with PD for >10 years experienced strong motor fluctuations, requiring constant trial and error with medication adjustment by her carer. Continuous symptom data helped her visualize fluctuations, understand their link to medication, and communicate more effectively with her neurologist, leading to an optimized treatment plan. A 50-year-old woman wore the sensor for 4 weeks before her first PD nurse consultation, allowing her to understand her treatment response, and motivated her to pursue advanced therapy previously avoided. A 55-year-old woman with PD for 12 years used the sensor for over a year, aiding self-management and stabilizing symptoms. As disease progressed, PD nurse consultations helped her adapt lifestyle to improve her quality of life.

Conclusion: AI-driven remote monitoring enhances PD nurses’ ability and efficiency to track disease progression, detect fluctuations, visualize medication effects, and ultimately provide personalized and timely care. It strengthens patient communication, supports personalized care, and empowers self-management. Most importantly, it allows nurses to focus on improving patients’ and caregivers’ quality of life, potentially reducing hospital visits and enhancing symptom control, medication adherence, and caregiver support.

To cite this abstract in AMA style:

F. Chmell, P. Lee, M. Sander. Enhancing Parkinson’s Nurse Care with AI-Driven Remote Symptom Monitoring [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/enhancing-parkinsons-nurse-care-with-ai-driven-remote-symptom-monitoring/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/enhancing-parkinsons-nurse-care-with-ai-driven-remote-symptom-monitoring/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley